Navigation Links
Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy
Date:6/24/2011

ies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com.

Forward-Looking Statements

This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10- Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of June 24, 2011 and expressly disclaims any duty to update information contained in this news release. '/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Amgen Announces Webcast of 2008 Third Quarter Financial Results
2. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
3. Call for Applications: The Amgen Award for Science Teaching Excellence
4. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
5. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
6. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
7. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
8. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
9. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
10. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
11. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Calif. , July 31, 2014 Rogne ... San Francisco Bay Area , has acquired a ... of Oxford,s commercialisation company. The potent anti-inflammatory activity of ... at the University of Oxford,s Sir William ... company, which has raised over $1.5 million in seed ...
(Date:7/31/2014)... DUBLIN , July 31, 2014 ... the "Global Genomics Market 2014-2018" report to ... Genomics is the study of the genetic ... to be a strong basis for the discovery and ... of human diseases or health conditions. Genomics is supported ...
(Date:7/31/2014)... and SHENZHEN, China , July 31, ... the purchase of an Irys™System by ... BioNano,s platform to enable comprehensive exploration of human structural ... various organisms of interest, including those where no reference ... to develop new methods for multiplexing on the Irys ...
(Date:7/31/2014)... July 31, 2014 Although RNA-Sequencing ... the first transcriptome-wide analyses appearing around 2008, RNA-Sequencing ... for RNA measurement. In the last several years, ... specific, work with smaller input amounts, process degraded ... blood samples). On the bioinformatics side, there have ...
Breaking Biology Technology:Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2
... we talked about Farm Aid and the focus of this organization ... as opposed to the large corporate farmer). I promised we would ... article. , ,This is no easy task, so I will try ... this article is mostly drawn from Burrill & Companys Biotech 2005 ...
... Waukesha, Wis . -- GE Healthcare , a ... in Waukesha, will provide three LOGIQ Book XP ultrasound ... and their athletic training staffs at the U.S. Olympic ... N.Y.; and Chula Vista, Calif. The systems and training ...
... Newport Beach, Calif., last week, the conference is a two-day ... to see great new products, meet entrepreneurs and network with ... head home with a stack of business cards and a ... the DEMO conference is over until February when we do ...
Cached Biology Technology:The worldwide growth of ag biotech 2The worldwide growth of ag biotech 3The worldwide growth of ag biotech 4Now the real work begins 2Now the real work begins 3
(Date:7/31/2014)... to be a key gene responsible for hearing in mammals. ... of the inner ear that contracts and expands rapidly to ... horn, amplify sound waves to make hearing more sensitivity. ... online edition of Molecular Biology and Evolution , Peng ... evolved to play a critical role in the ultrasonic hearing ...
(Date:7/31/2014)... Latinos are the largest minority group in the United ... of Latinos are obese and are 1.2 times as ... , NYU College of Nursing student researcher Lauren Gerchow, ... factors that contribute to this problem by compiling a ... patterns in Latina women recently published in Nursing ...
(Date:7/31/2014)... hidden hazard lurks beneath many of the roughly ... The hazard is corrosion in parts of underground ... leaks and contamination of groundwater, a source of ... nine states have reported many rapidly corroding gas ... incidents are generally associated with use of gasoline-ethanol ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2NIST corrosion lab tests suggest need for underground gas tank retrofits 2
... in a white lab coat hunched over a microscope ... the scientists who will meet at The American Physiological ... October 8-11 in Virginia Beach, Virginia. , ... animals that hibernate for months without suffering significant muscle ...
... In a new twist on the slogan “milk does ... staple as a contrast agent in gastrointestinal imaging exams—with ... the annual meeting of the Radiological Society of North ... bowel distension and enhancement as we see with the ...
... Scientists at the University of California, San Diego and ... by Bacillus thuringiensis, a bacterium sprayed on crops by ... at treating hookworm infections in laboratory animals. , ... of the Proceedings of the National Academy of Sciences, ...
Cached Biology News:What animals can tell us about hemorrhage, organ transplants and aging 2What animals can tell us about hemorrhage, organ transplants and aging 3What animals can tell us about hemorrhage, organ transplants and aging 4Got inexpensive contrast agent? Milk plays new role in imaging 2Bacterial protein shows promise in treating intestinal parasites 2Bacterial protein shows promise in treating intestinal parasites 3
Comp Dim: chamber L W D 45 45 0.8 mm chamber maximum volume 1500 μL...
... binding) polystyrene surface is hydrophobic in ... interactions,• Is suitable primarily for the ... antibodies, that have large hydrophobic regions ... Binding capacity of approximately 250 ng ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (M0156) ... assistance. Material: polystyrene flat bottom ...
... • Reusable, press-to-seal gasket and cover ... and disassembled for hybridizing and imaging thick ... with up to a 13 mm diameter. ... Minimize specimen handling, eliminate evaporation and leaking ...
Biology Products: